Programy EUREKA & Eurostars a Česká republika Svatopluk Halada AIP ČR Praha , 11. 9. 201 3
EUREKA and Eurostars - European Commission>R&D SMEs from Spain, Romania and Finland >Integration of...
Transcript of EUREKA and Eurostars - European Commission>R&D SMEs from Spain, Romania and Finland >Integration of...
© EUREKA Secretariat 2010
EUREKA and Eurostars
SMEs at the heart of ground breaking biotech innovations
Luuk Borg
> 2
© EUREKA Secretariat 2010
> EUREKA is a public network supporting R&D businesses > Established in 1985 by French President Mitterrand and German Chancellor
KohlEUREKA is :
• Intergovernmental initiative(39 Members – EU 27, European Commission + 11 other European countries)
• Financed using national public and private funding
• Market-oriented (Projects must result in a marketable product, process or service)
• Bottom-up (The consortium decides on the project aim. No thematic restriction)
Since 1985, 29 billion euro of public-private investment has been mobilised to support some
3,100 EUREKA projects
EUREKA – What is it ?
> 3
© EUREKA Secretariat 2010
EUREKA supports three types of projects
Cluster Projects
Long-term, strategically-significant initiativesLarge number of participants, many from Europe’s major companiesDevelop generic technologies of key importance to European competitiveness
Individual Projects (E!1782; E!1784…)
Small, shorter-term projectsInvolve participants from at least two member countriesResult in a product, process or service with a significant advance in their sector
Eurostars Projects
Small, short-term projects, involving participants from at least two member countriesConsortium leader is an R&D-performing SMEProgrammed jointly with the European Commission
Umbrellas; Thematic network of public authorities and sectoral experts
EUREKA Projects
> 4
© EUREKA Secretariat 2010
EUREKA member countries
AustriaBelgiumCroatiaCyprusCzech RepublicDenmark
EstoniaEuropean UnionFinlandFranceFYROMGermanyGreeceHungaryIcelandIrelandIsraelItalyLatviaLithuaniaLuxembourg
MaltaMonacoThe NetherlandsNorwayPolandPortugalRomaniaRussian FederationSan MarinoSerbiaSlovakia SloveniaSpainSwedenSwitzerlandTurkeyUkraineUnited Kingdom
> 5
© EUREKA Secretariat 2010
Global Overview : EUREKA 1985 - 2010
In 25 years, EUREKA has endorsed 4000 projects for a total value of 29 Billions euros
3096 projects are Individual projects, 567 are Clusters type and 346 are Eurostars
7.6 B€ for Individual projects, 21 B€ for Clusters and 0.5 B€ for Eurostars
> 6
© EUREKA Secretariat 2010
Over 1000 running projects
> 7
© EUREKA Secretariat 2010
A few success stories
> 8
© EUREKA Secretariat 2010
EUREKA Success Stories
> 9
© EUREKA Secretariat 2010
> 10
© EUREKA Secretariat 2010
> 11
© EUREKA Secretariat 2010
> 12
© EUREKA Secretariat 2010
EUREKA : Historical Trends by Number of Projects
EUREKA Projects Endorsed 1985 - 2010
0
50
100
150
200
250
300
350
400
85H 86L 86S 87M 88C 89V 90R 91H 92T 93P 94L 95I 96B 97L 98L 99I 00H 01M 02T 03C 04P 05M 06P 07R 08L 09L 10B
Num
ber o
f pro
ject
s
Individual Projects Clusters Eurostars
> 13
© EUREKA Secretariat 2010
EUREKA : Type of Participants
EUREKA Type of Participants
(not including clusters participant data from 1999 onwards)
0%
10%20%
30%40%
50%
60%70%
80%90%
100%
85H 86L 86S 87M 88C 89V 90R 91H 92T 93P 94L 95I 96B 97L 98L 99I 00H 01M 02T 03C 04P 05M 06P 07R 08L* 09L* 10B
SME Large company Research Institute University Other
*Includes Eurostars dataAssumption for 2010
Includes all Eureka Projects (Individual Projects, Clusters and Eurostars)
> 14
© EUREKA Secretariat 2010
Adoption by theEuropean Parliament
10 April 2008
Adoption by theCouncil of Ministers
23 June 2008
Eurostars exploits Article 169 of the EU Treaty, requiring co-decision by the European Parliament and Council of Ministers
Eurostars a Joint programme
The Eurostars Programme is powered by EUREKA and the European Community
> 15
© EUREKA Secretariat 2010
EUREKA The Leverage Effect
> 16
© EUREKA Secretariat 2010
EUREKA Impact Results shown at the Ministerial Conference
• 1000 Final Report received and anlaysed (20% of the overall participants)For the Period 2000-2005
• Final Report are based on Participants data and assumptions (not an audit)
> 17
© EUREKA Secretariat 2010
Ex-Post ImpactAnalysis of the Final Report 2000-2005
Public Fund 1M€
Achieved Commercial Turnover
3 M€
Private Fund 2.5 M€
Expected Commercial Turnover
10 M€
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
Leverage effect on Commercial Turnover : 13
Leverage Effect on Private Fund : 2.5
> 18
© EUREKA Secretariat 2010
Global overview - Market Areas
Trends are quite SimilarMedical & Health = 25-30% ; ICT = 20-25%; Industrial Product =15-20%; Services =10-15%
Applications Submitted - Type of Market Areas - By Total Costs
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Cut off 4 Cut off 3 Cut off 2 Cut off 1
Other
Energy
AgricultureConstruction & Transport
ServicesIndustrial products
ICT
Medical & Health
> 19
© EUREKA Secretariat 2010
Eurostars in the Medical/Healthcare Field
> 254 Project Applications with market focus on Medical/Healthcareinvolving:
> 823 Participants, of which> 527 R&D SMEs> 394,200,000 € total value
> 56 Approved Projects with market focus on Medical/Healthcare involving:
> 184 Participants> 89,000,000 € total value> 117 R&D SMEs involved> 65,400,000 € contribution by R&D SMEs> 23 Eurostars Member Countries
> 20
© EUREKA Secretariat 2010
Value of Approved Eurostars Projects:In the Medical/Health Care Market
-
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
AT BE CH CZ DE DK EE ES FI FR GR HU IL IS IT LT NL NO PL PT RO SE UK
Tota
l Val
ue o
f Pr
ojec
ts (
Mill
ions
€)
Total Value of Projects (89 M€)
Contribution by R&D SMEs (65.4 M€)
> 21
© EUREKA Secretariat 2010
Technological Fields involved in Medical/Health Care Applications
138
33
6 4 3
0
20
40
60
80
100
120
140
160
BIOLOGICAL SCIENCES /TECHNOLOGIES
ELECTRONICS, IT ANDTELECOMS TECHNOLOGY
INDUSTRIALMANUFACTURING, MATERIAL
AND TRANSPORT
MEASUREMENTS ANDSTANDARDS
OTHER INDUSTRIALTECHNOLOGIES
Technology Area
Num
ber
of A
ppro
ved
Proj
ects
> 22
© EUREKA Secretariat 2010
Project examples 1.
> AID (Medical Imaging)> R&D SMEs and Universities from France and Germany> development of intracardiac diagnosing product providing realtime 3D image
capability while maintaining high resolution for 2D scans. AID's devices will open up new cardiac surgical modality in offering on-demand volume examination, essential in electrophysiology.
> 1.9 M€
> DEPSTER (Pharmaceutical Products)> R&D SMEs, Research Institutes and Universities from France,
Germany and Sweden> a new therapy for the treatment of depressive disorders> 2.2 M€
> 23
© EUREKA Secretariat 2010
Project examples 2.
> DISC-SCREEN (Pharmaceutical development)> R&D SMEs from Spain, Romania and Finland> Integration of several high throughput techniques for the discovery of new drug
candidates targeting neoplasic related diseases.> 1.5 M€
> pharmAID (Electronics, Logistics)> R&D SMEs, SMEs and Universities from Italy and Switzerland> Logistics control, storage monitoring and anti-counterfeiting of pharmaceutical
products to prevent drugs' counterfeiting, certify drugs' integrity against unsuitable ambient conditions & track drugs along the supply chain.
> 2.1 M€
> 24
© EUREKA Secretariat 2010
EurostarsThe Leverage Effect Expected
> 25
© EUREKA Secretariat 2010
Risk v Return
Technological Risk (degree of Innovation)
Successrate
Marketshare
0 %
100%
Market potential
1000 of failed start-upVolvo
Very SuccesfulSME
SuccesfulSME
Champione.g : Tom Tom
Eurostars Projects
EUREKA Individual / Cluster Projects
> 26
© EUREKA Secretariat 2010
SME profile
Average Annual Turnover of the RD SMEs
2,768,916 €
2,195,670 €
RD SME
cut off 1 cut off 2
Number of employees of the RD SMEs
28
23
Cut-Off 1 Cut-Off 2
> 27
© EUREKA Secretariat 2010
Expected Growth impact
Average Employement Growth Expected (% of FTE)
58%
4% 3% 2%0%
10%
20%
30%
40%
50%
60%
70%
RD SME Largecompany
ResearchInstitute
University
Average Annual Turnover Growth Expected (% of Annual turnover)
181%
6% 4% 3%0%
20%
40%
60%
80%
100%
120%
140%
160%
180%
200%
RD SME Largecompany
ResearchInstitute
University
> 28
© EUREKA Secretariat 2010
Main motivations for participation
Main motivations for participating in Eurostars
Mutual sharing of human and
financial resources
Develop new products/services/
processes
Complement skills with the skills of other participants
Obtain public funds
Access new markets
Mutual sharing of existing know-how
Share the risk Develop strategic co-operation
with competitors
Other 0.00%
10.00%
20.00%
30.00%
40.00%
50.00%
60.00%
70.00%
80.00%
90.00%
100.00%
> 29
© EUREKA Secretariat 2010
Annual Report 2008 : 7 Key Messages
1. The first cut offs have been very successful.215 applications received in the first cut off 317 applications received in the second cut off
2. Eurostars Target has been reached74% of the applicants are R&D SMEs75% of the funds goes to R&D SMEs
3. High Success Rate 42% of the projects application (90) were funded in the first cut off
4. Good Scientific IntegrationCommon Eligibible and Evaluation CriteriasCentral Evaluation System
5. Good Management Integration One dedicated implementing body : The EUREKA Secretariat Unique Added Value of the EUREKA Network (promotion, local contact with SMEs)
6. Good Funding SynchronisationThe Funding allocation respected the order of the ranking List.90 projects could be funded thanks to the increase of funding from 10 Countries.
7. Continous Progress On Eurostars Funding rules compliancy (50% needs an industrial partner to fund a university)Delegation agreement still pending as well as bilateral agreements
> 30
© EUREKA Secretariat 2010
Survey comments from registrants MTR
On the Programme:“Most efficient programme”“Completely adapted to SME’s“Accessible scheme”“User-friendly”“Great support
On the funding: “synchronization of national funding”
> “Different rules and timing in countries”> “time to contract could go faster”
On the evaluation:“The evaluation report (consensus report) was too short”
> 31
© EUREKA Secretariat 2010
Successful models to pursue…
The Opportunities preparing for future Framework Programmes, CIP attracting SMEs
Joint Eurostars Model:simple procedurescentral evaluationdecentralised funding combining national, regional and European funding
Easy access for SME driven projects:Simple proceduresShort time to contractSingle entry points
Support of SMEs along the innovation value chain:financial (second round) through EIB AIF, RSFFservice (IPR, support through national networks)
> 32
© EUREKA Secretariat 2010
Thank you!
Luuk BorgEuropean Secretariat of Eureka